Tom Oostrom (1964) has been Managing Director of the Dutch Kidney Foundation since 2010. He started as head of the policy section in 2005. With the motto "Life comes first" the Kidney Foundation gives everything to make sure kidney patients survive ánd their quality of life improves. Tom Oostrom learned from practice: he started out as a nurse. His drive is to make a real difference for kidney patients, to help make their lives livable.
Since 2012 Oostrom has been the chair of the cooperating healthcare funds (Samenwerkende Gezondheidsfondsen) in which 21 large funds are united. He is also a member of the Regiegroep Life Sciences & Health and is committed to promote active involvement of healthcare funds in the topsector policy. Oostrom is also vice-president of the NPHF, Federation for Health. In Leiden Oostrom studied to become a nurse (1986). He studied Policy & Management in Healthcare at Erasmus University Rotterdam (1991).
Frank Miedema (1954) studied biochemistry at the University of Groningen, specializing in immunology, with a minor in Philosophy of Science. He obtained a PhD from the University of Amsterdam at the Central Laboratory of the Blood Transfusion Service (CLB), now Sanquin. There, from 1983 he was project leader immunovirology of HIV/AIDS as part of the Amsterdam Cohort Studies. In 1996 he was appointed full professor at AMC/University of Amsterdam and in became Director of Sanquin Research in 1998. In 2004 he became head of the Immunology department at the University Medical Center Utrecht. From 2009 he is dean and vice chairman of the Executive Board at the University Medical Center Utrecht. He is one of the initiators of www.scienceintransition.nl/english. Science in Transition believes that the scientific incentive and reward system is in need of fundamental reform. Next to Science for Science (articles in journals), the added value for society needs to be more appreciation and societal stakeholders should be involved more integrally in the production of knowledge.
Albert Scherpbier is Professor in Quality improvement in medical education. He studied Philosophy and Medicine at the University of Groningen. Since 1980, he has worked at the Academic Hospital Groningen. Since 1991 he works at Maastricht University. He served as Head Skillslab and as Scientific Director of the Institute for Education. From 2009 to 2011 he served as Associate Dean of Education, Faculty of Health, Medicine and Life Sciences, Maastricht University. Since 2011 he is Dean of the Faculty of Health, Medicine and Life Sciences of Maastricht University and vice chair of the Maastricht University Medical Center. He is chairman of the board of INSCITE and CEO of Scannexus.
In his research he is particularly interested in learning at the workplace and skillstraining. He obtained his PhD defending a thesis ‘’Quality of skills training assessed’’ at Maastricht University. Albert Scherpbier is involved in various national and international associations and committees, especially in the medical educational field.
Peter Hilbers (1957) is fulltime professor "BioModeling and BioInformatics" at the biomedical engineering department of the TU Eindhoven. He studied Mathematics at the University of Groningen, where he also completed his PhD study on 'Mapping of algorithms on processor networks' in 1989. From 1989 till 1996, he worked at the Shell Laboratories in Amsterdam. He was appointed as a part-time Professor on "Large scale computing and applications" at the Eindhoven University in 1993, and as a full Professor in 1996. He is leading the division "BIOMedical Imaging & Modeling" and also heading the Computational Biology group of the BioMedical Engineering department of the TU Eindhoven. Since 2005 he is involved in the research and edcucational programs of the Sino-Dutch Biomedical & Information Engineering School of Northeastern University, Shenyang, China. In October 2007 he became the dean of the department of BioMedical Engineering of the TU/e.
Dr. Hogendoorn is Professor of Pathology at Leiden University, The Netherlands, and a senior pathology consultant at the Leiden University Medical Center. Currently Dr. Hogendoorn serves as Member and Dean in the Executive Board of the Leiden University Medical Center in Leiden, The Netherlands. He completed his Medical and PhD studies at Leiden University followed by his residency in anatomic pathology. He completed fellowships in oncological pathology at the Dutch Cancer Institute, Amsterdam and Memorial Sloan Kettering Cancer Center, New York. For the last 25 years, his scientific research has focused on the pathogenesis, morphology and molecular pathology of bone - and soft tissue tumours, resulting in over 400 original publications, several review articles and 23 book chapters.
He has had or has a number of national and international scientific and administrative positions, including chairmanship of the Netherlands Committee on Bone tumours, the Pathology and Biology subcommittee of the EORTC Soft tissue and Bone Sarcoma Group, European Osteosarcoma Intergroup, EuroEwing Consortium, and membership of the Board of the Connective Tissue Oncology Society and European Musculoskeletal Oncology Society. In recognition of his contributions to pathology and research in bone tumours he was asked in the 2002 Working group of the World Health Organisation on classification of tumours of soft tissue and bone. He received a membership of honour in recognition of his repeated courses on pathology of bone tumours from the Belgium Society of Pathology, the European Oswald Vander Vekenprijs (2008), as well as the Corrine Farrel Award (International Skeletal Society) twice (1994 & 1998), and the Jeremy Jass prize for research excellence in 2011 and 2016, as well as prices for postgraduate teaching. He holds a prestigious chair as visiting professor at the University of Oxford and the University of Brussel.